ALECTOR SHARES FALL 26.5% PREMARKET AFTER CO'S ALZHEIMER’S DISEASE DRUG FAILS TO MEET MAIN GOAL OF MID-STAGE TRIAL

Reuters · 11/26 11:10

Please log in to view news